TP53 mutation in GBM — common, adverse prognostic; not directly targeted. Per usual algor...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | BMA-TP53-MUT-GBM |
|---|---|
| Type | Actionability |
| Status | reviewed 2026-04-27 | pending_clinical_signoff | actionability review required |
| Diseases | DIS-GBM |
| Sources | SRC-CIVIC SRC-NCCN-CNS-2025 |
Actionability Facts
| Biomarker | BIO-TP53-MUTATION |
|---|---|
| Variant | any pathogenic |
| Disease | DIS-GBM |
| ESCAT tier | IIIB |
| Evidence summary | TP53 mutation in GBM — common, adverse prognostic; not directly targeted. Per usual algorithm. |
Notes
ESCAT IIIB. Gene-level cell.
Used By
No reverse references found in the YAML corpus.